YAP1 and cancer: By treating skin cancer cells with an anti-VEGFR3 specific peptide [26], we show that suppression of VEGF-C/VEGFR3 signaling significantly reduces YAP1 and Slug expression and diminishes the migration, invasion and cancer stemness of the cells.